B. Mirtsching
- Oncology top 2%
- Cancer Treatment and Pharmacology 12
- Colorectal Cancer Treatments and Studies 8
- Neutropenia and Cancer Infections 4
- Cancer Research top 10%
- Hepatology top 5%
-
- Lung Cancer Treatments and Mutations 5
- Hematology top 10%
- Erythropoietin and Anemia Treatment 7
-
- Blood disorders and treatments 4
- Chronic Lymphocytic Leukemia Research 3
-
- Statistical Methods in Clinical Trials 4
- Co-authors
- Heinz‐Josef LenzAllen Lee CohnEric Van CutsemAndrew W. PippasRobert J. MayerPhilip J. GoldN. AzarniaJames N. Atkins
- Cited by
- OncologyCancer ResearchHepatology
- Journals
- Journal of Clinical Oncology (15 papers)Clinical Breast Cancer (2 papers)Survey of Ophthalmology (2 papers)
- Partner nations
- United StatesBelgiumCanada
In The Last Decade
B. Mirtsching
26 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 63
- Oncology 1.1k
- Cancer Research 288
- Hepatology 131
- Pulmonary and Respiratory Medicine 459
- Hematology 104
Countries citing papers authored by B. Mirtsching
This map shows the geographic impact of B. Mirtsching's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Mirtsching with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Mirtsching more than expected).
Fields of papers citing papers by B. Mirtsching
This network shows the impact of papers produced by B. Mirtsching. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Mirtsching. The network helps show where B. Mirtsching may publish in the future.
Co-authorship network
The 25 scholars most cited alongside B. Mirtsching, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 58 | |
| 2 | 2011 | 16 | |
| 3 | 2010 | 7 | |
| 4 | Phase III Study Comparing Gemcitabine Plus Cetuximab Versus Gemcitabine in Patients With Advanced Pancreatic Adenocarcinoma: Southwest Oncology Group–Directed Intergroup Trial S0205breakdown → | 2010 | 500 |
| 5 | Final results of a large, community-based, prospective study evaluating the impact of first and subsequent cycle pegfilgrastim on neutropenic events in patients receiving myelosuppressive chemotherapy | 2007 | 1 |
| 6 | A phase II, randomized, open-label study to assess the efficacy of extended-dose schedule administration of darbepoetin alfa in cancer patients with chemotherapy-induced anemia | 2007 | 1 |
| 7 | 2007 | 41 | |
| 8 | 2006 | 420 | |
| 9 | 2005 | 6 | |
| 10 | 2005 | 20 | |
| 11 | 2005 | 27 | |
| 12 | 2005 | 2 | |
| 13 | 2004 | 7 | |
| 14 | 2004 | 17 | |
| 15 | 2004 | 5 | |
| 16 | 2004 | 1 | |
| 17 | 2004 | 80 | |
| 18 | 2004 | 3 | |
| 19 | Every-2-Week Darbepoetin Alfa Is Comparable to rHuEPO in Treating Chemotherapy-Induced Anemia | 2002 | 10 |
| 20 | 1992 | 3 |
About B. Mirtsching
B. Mirtsching is a scholar working on Hematology, Oncology, Statistics and Probability, Genetics and Pulmonary and Respiratory Medicine, having authored 27 papers that have together received 1.3k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (12 papers), Colorectal Cancer Treatments and Studies (8 papers), Erythropoietin and Anemia Treatment (7 papers), Lung Cancer Treatments and Mutations (5 papers), Blood disorders and treatments (4 papers), Neutropenia and Cancer Infections (4 papers), Statistical Methods in Clinical Trials (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (288 citations), Hepatology (131 citations), Pulmonary and Respiratory Medicine (459 citations) and Hematology (104 citations). B. Mirtsching has collaborated with scholars based in United States, Belgium and Canada. Frequent co-authors include Heinz‐Josef Lenz, Allen Lee Cohn, Eric Van Cutsem, Andrew W. Pippas, Robert J. Mayer, Philip J. Gold, N. Azarnia, James N. Atkins, James L. Abbruzzese and Ralph Wong. Their work appears in journals such as Journal of Clinical Oncology, Clinical Breast Cancer, Survey of Ophthalmology, BMC Cancer and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.